Biodesix(US:BDSX) Globenewswireยท2025-10-20 10:00Core Points - Biodesix, Inc. will release its financial results for Q3 2025 on November 3, 2025, after market close [1] - A conference call and webcast will be held at 4:30 p.m. Eastern Time on the same day to discuss the results and provide a business update [1] - Registration links for the webcast and Q&A session are available for analysts and listeners [2] Company Overview - Biodesix is a leading diagnostic solutions company focused on improving clinical care and outcomes for patients [3] - The company offers diagnostic tests such as Nodify Lung Nodule Risk Assessment and IQLung Cancer Treatment Guidance, which aid in clinical decision-making for lung disease [3] - Biodesix Development Services support biopharmaceutical and life sciences institutions in developing diagnostic tests and therapeutics [3]